nano-tRNAseq (Coming soon)
Nano-tRNAseq enables comprehensive sequencing of tRNA molecules in their full-length, native state, allowing for simultaneous quantification of tRNA abundance and detection of tRNA modifications.
Immagina has adapted this exclusively licensed innovative technology with improvements to the published methods to provide a unique and all-inclusive nano-tRNAseq service offering that includes multiplexing, extensive quality control, and interactive bioinformatics reporting:
- High Specific Simplified Workflow: with a single library preparation without cDNA conversion and PCR amplification we can achieve the selective isolation of tRNA molecules starting from total RNA.
- Enhanced Efficiency: the sequencing on ONT platform coupled with improved base-calling increases significantly the efficiency of the data analysis.
- Broad Sample Compatibility: The technology is compatible with cells and tissues coming from all living organisms.
Suitable for: All cell lines and tissues.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
The first method enabling simultaneous quantification of tRNA abundance and detection of tRNA modifications is now available, exclusive from Immagina.
